Acetyl-l-carnitine is an ester of l-carnitine, both endogenous molecules, with a vital role in lipid metabolism. Exogenously delivered acetyl-l-carnitine is endowed with neuroprotective and neurotrophic actions due to its antioxidant and metabolic properties. Moreover, acetyl-l-carnitine is an epigenetic regulator of genes involved in analgesia such as the metabotropic glutamate 2 receptor in the presynaptic neurons and of neurotrophic factors including nerve growth factor. Accordingly, its long-term neurotrophic and analgesic activity has been confirmed in animal models of chronic inflammatory and neuropathic pain and in clinical studies in patients with peripheral neuropathies. The aim of this narrative review was to summarise the available evidence on the usefulness of acetyl-l-carnitine in the treatment of peripheral neuropathies.

Acetyl-l-Carnitine in the Treatment of Peripheral Neuropathies: A Narrative Review / D.M.M. Fornasari. - In: PAIN AND THERAPY. - ISSN 2193-8237. - 15:(2026), pp. 601-622. [10.1007/s40122-026-00826-x]

Acetyl-l-Carnitine in the Treatment of Peripheral Neuropathies: A Narrative Review

D.M.M. Fornasari
Primo
2026

Abstract

Acetyl-l-carnitine is an ester of l-carnitine, both endogenous molecules, with a vital role in lipid metabolism. Exogenously delivered acetyl-l-carnitine is endowed with neuroprotective and neurotrophic actions due to its antioxidant and metabolic properties. Moreover, acetyl-l-carnitine is an epigenetic regulator of genes involved in analgesia such as the metabotropic glutamate 2 receptor in the presynaptic neurons and of neurotrophic factors including nerve growth factor. Accordingly, its long-term neurotrophic and analgesic activity has been confirmed in animal models of chronic inflammatory and neuropathic pain and in clinical studies in patients with peripheral neuropathies. The aim of this narrative review was to summarise the available evidence on the usefulness of acetyl-l-carnitine in the treatment of peripheral neuropathies.
Acetyl-l-carnitine; Epigenetic drugs; Neuropathic pain
Settore BIOS-11/A - Farmacologia
2026
13-mar-2026
Article (author)
File in questo prodotto:
File Dimensione Formato  
unpaywall-bitstream-1033343612.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Licenza: Creative commons
Dimensione 977.57 kB
Formato Adobe PDF
977.57 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1242756
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
  • OpenAlex ND
social impact